Tonix Pharmaceuticals
Company Overview
Overall Headcount Trend
Overall Headcount Trend
Company growth over the last 12 months
Salaries
Community Salary Data
Help build salary transparency at Tonix Pharmaceuticals. Share your compensation anonymously.
Reviews
Jobs
About Tonix Pharmaceuticals
Tonix is a biopharmaceutical company, publicly traded on NASDAQ (ticker: TNXP). The Company is focused on commercializing, developing, discovering and licensing therapeutics to treat and prevent human disease. Tonix markets Zembrace® SymTouch® (sumatriptan injection) 3 mg and Tosymra® (sumatriptan nasal spray) 10 mg. Zembrace SymTouch and Tosymra are each indicated for the treatment of acute migraine with or without aura in adults. Tonix’s development portfolio is composed of central nervous system (CNS), rare disease, immunology and infectious disease product candidates. Tonix’s CNS development portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. The Company’s immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer. Tonix’s infectious disease pipeline consists of a vaccine in development to prevent smallpox and monkeypox, which also serves as the live virus vaccine platform or recombinant pox vaccine platform for other infectious diseases.
Company Information
- Company Type
- In-House Team
- Company Size
- Founded
- 2007
- Headquarters
- Chatham
Why Work at Tonix Pharmaceuticals?
Discover what makes Tonix Pharmaceuticals a great place to build your marketing career. View salary data, benefits, and employee insights on the other tabs.
